The success of primary angioplasty: Beyond TIMI flow Summary of a presentation held at acute cardiac care meeting in Paris, October 2008

References

• Van de Werf, F, Bax, J, Betriu, A, Blomstrom-Lundqvist, C, Crea, F, Falk, V, , et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J. 2008;29:2909–45. Epub 12 Nov 2008.
   PubMed Web of Science ®Google Scholar
• Kalla, K, Christ, G, Karnik, R, Malzer, R, Norman, G, Prachar, H, , et al. Vienna STEMI Registry Group. Implementation of guidelines improves the standard of care: The Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry). Circulation 2006;113:2398–405. Epub 15 May 2006
   PubMed Web of Science ®Google Scholar
• Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, et al. Thrombolysis in myocardial infarction (TIMI) trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987; 76: 142–54
   PubMed Web of Science ®Google Scholar
• [No authors listed] The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO angiographic investigators. N Engl J Med. 1993;329:1615–22
   PubMed Web of Science ®Google Scholar
• Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, et al. Clinical implications of the “no reflow” phenomenon: a predictor of complications and left ventricular remodelling in reperfused anterior wall myocardial infarction. Circulation 1996; 93: 223–8
   PubMed Web of Science ®Google Scholar
• Galiuto L, Garramone B, Scarà A, Rebuzzi AG, Crea F, La Torre G, et al. AMICI Investigators. The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the multicenter AMICI study. J Am Coll Cardiol. 2008; 51: 552–9
   PubMed Web of Science ®Google Scholar
• Stone GW, Peterson MA, Lansky AJ, Dangas AJ, Mehran R, Leon MB. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol. 2002; 39: 591–7
   PubMed Web of Science ®Google Scholar
• Claeys MJ, Bosmans J, Veenstra L, Jorens P, De Raedt H, Vrints CJ. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. Circulation 1999; 99: 1972–7
   PubMed Web of Science ®Google Scholar
• De Luca, G, Suryapranata, H,, de Boer, MJ, Ottervanger, JP, Hoorntje, JCA, Gosselink, ATM, , et al. Ongoing tirofiban in myocardial infarction evaluation (on-time) study group. Combination of electrocardiographic and angiographic markers of reperfusion in the prediction of infarct size in patients with ST-segment elevation myocardial infarction undergoing successful primary angioplasty. Int J Cardiol. 2007;117:232–7. Epub 8 Aug 2006.
   Google Scholar
• Buller, CE, Fu, Y, Mahaffey, KW, Todaro, TG, Adams, P, Westerhout, CM,, , et al. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: Insights from the assessment of pexelizumab in acute myocardial infarction (APEX-AMI) trial. Circulation 2008;118: 1335–46. Epub 8 Sep 2008.
   Google Scholar
• van't Hof AWJ, Liem A, de Boer MJ, Zijlstra F. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group. Lancet 1997; 350: 615–9
   PubMed Web of Science ®Google Scholar
• van't Hof AWJ, Liem A, Suryapranata H, Hoorntje JCA, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: Myocardial blush grade: Zwolle myocardial infarction study group. Circulation. 1998; 97: 2302–6
   PubMed Web of Science ®Google Scholar
• De Luca, G, van't Hof, AWJ, de Boer, MJ, Hoorntje, JCA, Gosselink, ATM, Dambrink, JH,, , et al. Impaired myocardial perfusion is a major explanation of the poor outcome observed in patients undergoing primary angioplasty for ST-segment-elevation myocardial infarction and signs of heart failure. Circulation 2004;109:958–61. Epub 23 Feb 2004.
   Google Scholar
• Claeys MJ, Bosmans J, De Ceuninck M, Beunis A, Vergauwen W, Vorlat A, et al. Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction. Am J Cardiol. 2004; 94: 9–13
   PubMed Web of Science ®Google Scholar
• van't Hof AWJ, ten Berg J, Heestermans T, Dill T, Funck RC, van Werkum W, et al. Ongoing tirofiban in myocardial infarction evaluation (on-time) 2 study group. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (on-time 2): A multicentre, double-blind, randomised controlled trial. Lancet 2008; 372: 537–46
   PubMed Web of Science ®Google Scholar
• Vlaar PJ, Svilaas T, van der Horst IC, Diercks GF, Fokkema ML, de Smet BJ, et al. Cardiac death and reinfarction after 1 year in the thrombus aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): A 1-year follow-up study. Lancet 2008; 371: 1915–20
   PubMed Web of Science ®Google Scholar